Trials / Unknown
UnknownNCT00418041
Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- Hiroaki Shimokawa, MD, PhD · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study) is a large, prospective, hospital-based cohort study to investigate the following: * Characteristics of patients with chronic heart failure and prognostic risks of these patients. * Characteristics of patients with high risk for heart failure and critical factors which predict the development of symptomatic heart failure in these patients. * The incidence and prognostic impact of metabolic syndrome in patients with chronic heart failure. * The association between metabolic syndrome and the development of symptomatic heart failure.
Detailed description
The CHART-2 Study is a multicenter prospective observational cohort study identifying the characteristics, mortality and prognostic risks of patients with overt HF and patients without HF but who are at high risk for disease progression of cardiovascular diseases (CVD). The purposes of the study are as follows: 1. to elucidate characteristics of patients with overt HF and the associated prognostic risks 2. to elucidate characteristics of patients at risk for HF and the factors associated with CVD progression 3. to elucidate factors associated with the development of AHFS 4. to elucidate prevalence and prognostic impact of metabolic syndrome (MetS) in patients with overt HF 5. to elucidate the association between MetS and the development of AHFS 6. to elucidate the prevalence and prognostic impact of malignancy in patients with CVD 7. to elucidate the prevalence of patients needing home nursing care and the characteristics of bedridden patients with CVD.
Conditions
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2019-03-01
- Completion
- 2019-12-01
- First posted
- 2007-01-04
- Last updated
- 2015-05-12
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00418041. Inclusion in this directory is not an endorsement.